Abatacept Pregnancy Exposure Registry
| Status: | Recruiting |
|---|---|
| Conditions: | Arthritis, Rheumatoid Arthritis |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/3/2019 |
| Start Date: | September 30, 2006 |
| End Date: | December 31, 2019 |
| Contact: | Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email: |
| Email: | Clinical.Trials@bms.com |
Abatacept Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project: An Extension Study
The purpose of the abatacept pregnancy registry is to monitor planned and unplanned
pregnancies exposed to abatacept, to evaluate the possible teratogenic effects (that is, any
abnormal development) of this medication in the pregnancy outcome and to follow live born
infants for one year after birth.
pregnancies exposed to abatacept, to evaluate the possible teratogenic effects (that is, any
abnormal development) of this medication in the pregnancy outcome and to follow live born
infants for one year after birth.
For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com
Inclusion Criteria:
- Currently pregnant women who agree to the conditions and requirements of the study
including the interview schedule, release of medical records, and the physical
examination of live born infants
Exclusion Criteria:
- Women who come in first contact with the project after prenatal diagnosis of a fetal
abnormality
We found this trial at
1
site
Click here to add this to my saved trials
